Review Article

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review

Table 1

Survivals: RFA versus hepatic resection for HCC.

Author/YearStudy type
(RFA/resection)
Mean tumor size (cm)
(RFA/resection)
Overall survival (%)
(RFA versus resection)

Chen et al. [15], 2006RCT90/90ND/ND65.9 versus 64.0 (4-year)NS
Huang et al. [16], 2010RCT115/115ND/ND54.78 versus 75.65 (5-year).001
Vivarelli et al. [17], 2004Retrospective79/79ND/ND33 versus 65 (3-year).002
Montorsi et al. [18], 2005Prospective58/40ND/ND30 versus 53 (4-year).018
Ogihara et al. [19], 2005Retrospective40/474.6/7.439 versus 31 (5-year).79
Wakai et al. [20], 2006Retrospective64/85ND/ND30 versus 53 (10-year).012
Guglielmi et al. [21], 2008Retrospective23/33ND/ND45 versus 55 (5-year).7
Abu-Hilal et al. [22], 2008Retrospective34/343.0/3.857 versus 56 (5-year).3
Hiraoka et al. [23], 2008Retrospective105/59ND/ND59.3 versus 59.4 (5-year)NS
Ueno et al. [24], 2009Retrospective123/1102.0/2.763 versus 80 (5-year).06
Takayama et al. [25], 2009Retrospective1315/12351.6/1.895 versus 94 (2-year).28

HCC: hepatocellular carcinoma; ND: not described; NS: not significant; RFA: radiofrequency ablation.